E-LIB Suche - Ergebnisse für: Spampinato, U.

1

P.431 Serotonin2B receptor antagonists potentiate cocaine-i..:

Cathala, A. ; Revest, J.M. ; Spampinato, U.
European Neuropsychopharmacology. 29 (2019) - p. S306 , 2019

Link: https://doi.org/10.1016/..

2

Serotonin2B receptors exert a GABA-mediated inhibitory cont..:

Spampinato, U. ; Cathala, A. ; Devroye, C...
European Neuropsychopharmacology. 29 (2019) - p. S232 , 2019

Link: https://doi.org/10.1016/..

3

P.6.c.003 Serotonin 2C receptor inhibits dopamine transmiss..:

Cathala, A. ; Devroye, C. ; Maitre, M....
European Neuropsychopharmacology. 24 (2014) - p. S676 , 2014

Link: https://doi.org/10.1016/..

4

P.6.c.002 Blockade of central serotonin 2B receptors reduce..:

Devroye, C. ; Cathala, A. ; Drago, F...
European Neuropsychopharmacology. 24 (2014) - p. S675-S676 , 2014

Link: https://doi.org/10.1016/..

5

2.279 ADVERSE EVENTS TO ANTIPARKINSONIAN MEDICATIONS IN PAR..:

Perez-Lloret, S. ; Rey, M.V. ; Fabre, N....
Parkinsonism & Related Disorders. 18 (2012) - p. S135 , 2012

Link: https://doi.org/10.1016/..

6

2.284 IMPULSE-CONTROL DISORDERS IN PARKINSON'S DISEASE PATI..:

Perez-Lloret, S. ; Rey, M.V. ; Fabre, N....
Parkinsonism & Related Disorders. 18 (2012) - p. S136 , 2012

Link: https://doi.org/10.1016/..

7

2.280 RELATIONSHIP BETWEEN POLYPHARMACY AND FREQUENCY OF AD..:

Rey, M.V. ; Perez-Lloret, S. ; Spampinato, U...
Parkinsonism & Related Disorders. 18 (2012) - p. S135 , 2012

Link: https://doi.org/10.1016/..

8

2.282 FACTORS RELATED TO ORTHOSTATIC HYPOTENSION IN PARKINS..:

Perez-Lloret, S. ; Rey, M.V. ; Fabre, N....
Parkinsonism & Related Disorders. 18 (2012) - p. S136 , 2012

Link: https://doi.org/10.1016/..

9

S.20.03 Control of dopamine release by 5-HT2B receptors in ..:

Spampinato, U. ; Cathala, A. ; Panin, F....
European Neuropsychopharmacology. 21 (2011) - p. S218 , 2011

Link: https://doi.org/10.1016/..

10

Increased release of striatal dopamine after long-term trea..:

Spampinato, U ; Nowakowska, E ; Samanin, R
Journal of Pharmacy and Pharmacology. 35 (2011) 12 - p. 831-833 , 2011

Link: https://doi.org/10.1111/..

11

S.12.01 Physiological and therapeutic relevance of constitu..:

Spampinato, U. ; Cathala, A. ; Leggio, G.M....
European Neuropsychopharmacology. 20 (2010) - p. S181 , 2010

Link: https://doi.org/10.1016/..

12

Current status of inverse agonism at serotonin2A (5-HT2A) a..:

Aloyo, V.J. ; Berg, K.A. ; Spampinato, U...
Pharmacology & Therapeutics. 121 (2009) 2 - p. 160-173 , 2009

Link: https://doi.org/10.1016/..

13

POSTMORTEM PROOF OF EFFECTIVENESS OF ZONA INCERTA STIMULATI..:

Guehl, D. ; Vital, A. ; Cuny, E....
Neurology. 70 (2008) 16_part_2 - p. 1489-1490 , 2008

Link: https://doi.org/10.1212/..

14

Selective serotonin reuptake inhibitors enhance cocaine-ind..:

Bubar, M.J ; McMahon, L.R ; De Deurwaerdère, P..
Neuropharmacology. 44 (2003) 3 - p. 342-353 , 2003

Link: https://doi.org/10.1016/..

15

D-Amphetamine-induced behavioral sensitization: effect of l..:

Bjijou, Y ; De Deurwaerdere, P ; Spampinato, U..
Neuroscience. 109 (2002) 3 - p. 499-516 , 2002

Link: https://doi.org/10.1016/..